Cornell’s nearly 50-year-old Empathy, Assistance and Referral Service (EARS) will begin offering a new model of support this fall, including peer mentoring, training and outreach.
Dr. Geraldine McGinty, an esteemed clinical operations strategist, administrator and radiologist, has been appointed senior associate dean for clinical affairs at Weill Cornell Medicine, effective Sept. 1.
The autoimmune disease lupus may be triggered by a defective process in the development of red blood cells (RBCs), according to a study led by researchers at Weill Cornell Medicine. The discovery could lead to new methods for classifying and treating patients with this disease.
Lessons from suicide survivors – people who, despite the urge to die, find ways to cope and reasons to live – are seldom heard, but Cornell researchers and their colleagues have written one of the first studies to change that.
The pathogen listeria soon may become easier to track down in food recalls, thanks to a new genomic and geological mapping tool created by Cornell food scientists.
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
Cornell researchers “humanized” mice with microbiota from three global populations and found that microbial differences alone can impact immune responses.
Embark Veterinary, Inc. – a canine genetics startup company that graduated from Cornell’s McGovern Center incubator in late 2017 – announced $75 million in venture funding on July 26.
The 2020 nationwide lockdown India imposed in response to the COVID-19 pandemic caused disruptions that negatively impacted women’s nutrition, according to a new study from the Tata-Cornell Institute for Agriculture and Nutrition.
